222 related articles for article (PubMed ID: 32508354)
21. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib.
White WB; Faich G; Borer JS; Makuch RW
Am J Cardiol; 2003 Aug; 92(4):411-8. PubMed ID: 12914871
[TBL] [Abstract][Full Text] [Related]
22. Non-steroidal anti-inflammatory drugs for chronic low back pain.
Enthoven WT; Roelofs PD; Deyo RA; van Tulder MW; Koes BW
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD012087. PubMed ID: 26863524
[TBL] [Abstract][Full Text] [Related]
23. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
Grabosch SM; Shariff OM; Helm CW
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004121. PubMed ID: 29431861
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.
Thompson PA; Ashbeck EL; Roe DJ; Fales L; Buckmeier J; Wang F; Bhattacharyya A; Hsu CH; Chow SH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Hamilton SR; Jacobs ET; Martinez EM; Alberts DS; Lance P
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27530656
[TBL] [Abstract][Full Text] [Related]
26. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
Juthani VV; Clearfield E; Chuck RS
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs for assisted reproductive technology.
Nyachieo A; Siristatidis CS; Vaidakis D
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007618. PubMed ID: 31628860
[TBL] [Abstract][Full Text] [Related]
28. Protective Effects of Long-Term Usage of Cyclo-Oxygenase-2 Inhibitors on Colorectal Cancer in Genetically Predisposed Individuals and Their Overall Effect on Prognosis: A Systematic Review.
Narayana SH; Mushtaq U; Shaman Ameen B; Nie C; Nechi D; Mazhar IJ; Yasir M; Sarfraz S; Shlaghya G; Khan S
Cureus; 2023 Jul; 15(7):e41939. PubMed ID: 37588311
[TBL] [Abstract][Full Text] [Related]
29. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
31. Utilisation Pattern of Nonspecific Nonsteroidal Anti-Inflammatory Drugs and COX-2 Inhibitors in a Local Health Service Unit in Northeast Italy.
Chiroli S; Chinellato A; Didoni G; Mazzi S; Lucioni C
Clin Drug Investig; 2003; 23(11):751-60. PubMed ID: 17536889
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of non-steroidal anti-inflammatory drugs in preventing the recurrence of colorectal adenoma: a meta-analysis and systematic review of randomized trials.
Wang Y; Zhang FC; Wang YJ
Colorectal Dis; 2015 Mar; 17(3):188-96. PubMed ID: 25399784
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies.
Martín Arias LH; Martín González A; Sanz Fadrique R; Vazquez ES
J Clin Pharmacol; 2019 Jan; 59(1):55-73. PubMed ID: 30204233
[TBL] [Abstract][Full Text] [Related]
35. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
37. Non-steroidal anti-inflammatory drugs for acute gout.
van Durme CM; Wechalekar MD; Landewé RB; Pardo Pardo J; Cyril S; van der Heijde D; Buchbinder R
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010120. PubMed ID: 34882311
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
[TBL] [Abstract][Full Text] [Related]
39. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
